Vaccination Against Influenza Pre-discharge in Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.

Also called NCT06725927

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06725927
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06725927. Randomized; no masking; primary purpose prevention. Start 2024-12-31 (actual); primary completion 2025-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vaccination Against Influenza Pre-discharge in Heart Failure
Condition
Heart Failure
Intervention (Biological)
Influenza vaccination
Lead sponsor
Wroclaw Medical University (class: other)

Record details

Record id
cardio:ct-nct06725927
Content hash
8a18eda415d61ae548d1f778d476a329be019e718e8b17ababe3a0f108ced9c8